These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 38237711)

  • 1. Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy.
    Wang Y; Liu Y; Zhang J; Peng Q; Wang X; Xiao X; Shi K
    Acta Biomater; 2024 Mar; 176():51-76. PubMed ID: 38237711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies.
    Zhang J; Yu S; Peng Q; Wang P; Fang L
    Cancer Biol Med; 2024 Jan; 21(1):45-64. PubMed ID: 38172538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.
    Pan X; Zhang W; Guo H; Wang L; Wu H; Ding L; Yang B
    Biochem Pharmacol; 2023 Jul; 213():115596. PubMed ID: 37201875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases.
    Zhou S; Cheng F; Zhang Y; Su T; Zhu G
    Acc Chem Res; 2023 Nov; 56(21):2933-2943. PubMed ID: 37802125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cGAS-STING signaling in cancer immunity and immunotherapy.
    Du H; Xu T; Cui M
    Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights on the cGAS-STING Signaling Pathway During Herpesvirus Infections.
    Deng L; Xu Z; Li F; Zhao J; Jian Z; Deng H; Lai S; Sun X; Geng Y; Zhu L
    Front Immunol; 2022; 13():931885. PubMed ID: 35844623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Make it STING: nanotechnological approaches for activating cGAS/STING as an immunomodulatory node in osteosarcoma.
    O'Donoghue JC; Freeman FE
    Front Immunol; 2024; 15():1403538. PubMed ID: 39403376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-Mediated STING Activation for Cancer Immunotherapy.
    Li Y; Li X; Yi J; Cao Y; Qin Z; Zhong Z; Yang W
    Adv Healthc Mater; 2023 Jul; 12(19):e2300260. PubMed ID: 36905358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of cGAS and STING expression in cancer.
    Zhao C; Guo S; Ge S
    Int Immunopharmacol; 2024 Sep; 138():112556. PubMed ID: 38936059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan-based nano-micelles for potential anti-tumor immunotherapy: Synergistic effect of cGAS-STING signaling pathway activation and tumor antigen absorption.
    Zhang S; Zeng Y; Wang K; Song G; Yu Y; Meng T; Yuan H; Hu F
    Carbohydr Polym; 2023 Dec; 321():121346. PubMed ID: 37739513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer immunotherapy strategies that target the cGAS-STING pathway.
    Tian Z; Zeng Y; Peng Y; Liu J; Wu F
    Front Immunol; 2022; 13():996663. PubMed ID: 36353640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomaterial-enabled therapeutic modulation of cGAS-STING signaling for enhancing antitumor immunity.
    Liu Y; Fei Y; Wang X; Yang B; Li M; Luo Z
    Mol Ther; 2023 Jul; 31(7):1938-1959. PubMed ID: 37002605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advancements in cGAS-STING activation, tumor immune evasion, and therapeutic implications.
    Islam S; Islam MM; Akhand MRN; Park BY; Akanda MR
    Med Oncol; 2024 Oct; 41(11):291. PubMed ID: 39419913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cGAS-STING at the crossroads in cancer therapy.
    Wang R; Hussain A; Guo Q; Ma M
    Crit Rev Oncol Hematol; 2024 Jan; 193():104194. PubMed ID: 37931770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies.
    Huang M; Cha Z; Liu R; Lin M; Gafoor NA; Kong T; Ge F; Chen W
    Front Immunol; 2024; 15():1399926. PubMed ID: 38817608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cGAS/STING Pathway: A Novel Target for Cancer Therapy.
    Gan Y; Li X; Han S; Liang Q; Ma X; Rong P; Wang W; Li W
    Front Immunol; 2021; 12():795401. PubMed ID: 35046953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances of MnO
    Zhang T; Hu C; Zhang W; Ruan Y; Ma Y; Chen D; Huang Y; Fan S; Lin W; Huang Y; Liao K; Lu H; Xu JF; Pi J; Guo X
    Front Immunol; 2023; 14():1156239. PubMed ID: 37153576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cGAS/STING signaling and corresponding immune escape strategies of viruses.
    Ge Z; Ding S
    Front Cell Infect Microbiol; 2022; 12():954581. PubMed ID: 36189363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mn-based cGAS-STING activation for tumor therapy.
    Huang A; Zhou W
    Chin J Cancer Res; 2023 Feb; 35(1):19-43. PubMed ID: 36910853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.